A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression

NCT06570369 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
Depression
Healthy

Interventions

DRUG: SP-624
DRUG: Placebo

Sponsor

Sirtsei Pharmaceuticals, Inc.